Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To find the optimal (best) recommended dose of zotatifin and carboplatin to treat patients with metastatic or recurrent TNBC.
Epistemonikos ID: 034fbd5e7e8d9fcec825569385154e49bed8ad12
First added on: Aug 26, 2026